@article{52ba48499c4842f998e4d655b2fdd48c,
title = "Oral therapy for riboflavin transporter deficiency - What is the regimen of choice?",
keywords = "Adult, Ataxia, Brown-Vialetto-Van Laere syndrome-2, BVVLS2, Pharmacokinetics, Recessive, Riboflavin transporter deficiency, SLC52A2, Treatment",
author = "Sorina Gorcenco and Vaz, {Fr{\'e}d{\'e}ric M.} and Anna Tracewska-Siemiatkowska and Lisbeth Tranebj{\ae}rg and Cremers, {Frans P.M.} and Emil Ygland and Jen{\H o} Kicsi and Rendtorff, {Nanna Dahl} and Claes M{\"o}ller and Ulrika Kjellstr{\"o}m and Sten Andr{\'e}asson and Andreas Puschmann",
year = "2019",
doi = "10.1016/j.parkreldis.2018.10.017",
language = "English",
volume = "61",
pages = "245--247",
journal = "Parkinsonism & Related Disorders",
issn = "1873-5126",
publisher = "Elsevier",
}